Interferons Market is anticipated to reach US$ 13.8 Billion by the end of 2032

As per a latest industry analysis by Future Market Insights, the global interferons market  for interferons is anticipated to reach US$ 9.4 billion in 2022 and continue to grow at a CAGR of 3.9% from 2022 to 2032. By the end of 2032, the global market is projected to reach US$ 13.8 billion. A group of …

Europe Radiotherapy Patient Positioning Market is set at 4.1% CAGR from 2022 to 2032

As per Future Market Insights’ latest revised industry analysis, the Europe radiotherapy patient positioning market was radiotherapy patient positioning in Europe is anticipated to increase significantly between 2022 and 2032, with a 4.1% CAGR, topping US$ 124.9 Million in 2022. In terms of product type, the markers market will account for a sizeable portion of the …

Sinus Therapeutic Drugs Market is expected to witness a CAGR of over 6.3% by 2030

The global sinus therapeutic drugs market will Between 2020 and 2030, the market for sinus therapeutic pharmaceuticals is anticipated to grow at a CAGR of more than 6.3%. The development of biologics is amongst the most important factors catalysing the sinus therapeutic drugs market. Omalizumab is garnering interest of researchers and drug manufacturers alike. It has …

Surgical Booms Market is projected to grow at a moderate CAGR of 4.7% by 2022 and 2029

Surgical booms are also known as Equipment Management Systems (EMS). Surgical booms are used to constrain electrical wiring from the various equipment used in the OR. They also help organise the space in the OR by increasing the working space. Most surgical booms are suspended from the roof of the OR and are available in …

Biopsy Device Market is expand at a CAGR of 4.9% by 2023 and 2033

The Market report envelopes an all-in information of the Global Biopsy Device Market and the nature of the Market growth over the foreseeable period. In 2023, it is predicted that the global market for biopsy devices would be valued US$ 2.1 billion. By the end of 2033, the market is anticipated to be worth US$ 3.3 billion, …

Dengue Fever Treatment Market is expected to grow with a 20% CAGR during 2023 to 2033

The global Dengue Fever Treatment Market is predicted to generate a market value of US$ 877.82 Million in 2023 and a market value of US$ 5435.25 Million by 2023, with a CAGR of 20% from 2023 to 2033. From 2018 to 2022, the market for Dengue Fever Therapy grew at an 11% CAGR. According to …

Vascular Closure Devices Market are set to witness a growth rate of 5.4% CAGR reaching a total valuation of around US$ 2.4 Billion by 2032

The global Vascular Closure Device Market is expected to grow with an opulent CAGR of 5.4% during the forecast period from 2022 to 2032. The global market reached US$ 1.3 Bn in 2021 and is expected to enjoy a valuation of US$ 1.4 Bn by the end of 2022. The surge in usage of vascular closure devices …

Hand Eczema (HE) Treatment Market value of US$ 53 Million in 2023

The global Hand Eczema (HE) Treatment Market is expected to garner a market value of US$ 53 Million in 2023 and is expected to accumulate a market value of US$ 114.42 Million by registering a CAGR of 8% in the forecast period 2023 to 2033. The market for Hand Eczema (HE) Treatment registered a CAGR of 4% in the historical period 2018 to 2022. According …

Diabetic Macular Edema Market are set to witness a CAGR of 1.2% and be valued at around US$ 4.2 Billon by 2032

The global Diabetic Macular Edema Market Size is expected to reach a valuation of US$ 3.7 Bn by the end of 2022, and further expand at a CAGR of 1.2% from 2022 to 2032. The market is projected to reach a valuation of ~US$ 4.2 Bn by the end of 2032. An Uptake of Intravitreal Implants by Patients to Drive Growth of the …

Intratumoral Cancer Therapies Market value of US$ 212.96 Billion in 2023 | FMI

A recently published study by FMI expects the global Intratumoral Cancer Therapies market to garner a market value of US$ 212.96 Billion in 2023 and is expected to accumulate a market value of US$ 552.36 Billion by registering a CAGR of 10% in the forecast period 2023-2033. Growth of the Intratumoral Cancer Therapies market can be attributed to favorable regulatory frameworks for …